Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $76 to $71.
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $71
Truist Securities analyst Richard Newitter maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $76 to $71.
Related Posts
Marriott Q2 Earnings Top Estimates
Marriott International Inc (NASDAQ:MAR) reported second-quarter FY22 sales growth of 69.5% year-on-year to $5.34 billion, beating the consensus of $4.92 billion.…
3 Things You Already Own That Could Be Generating Thousands Of Dollars A Month For You Right Now
If you can generate enough passive income to cover your monthly expenses, you can escape the rat race and work when you want to.